The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Clinical Manifestations of AIDS in the Era of Pneumocystis Prophylaxis
Open accessAbstract
BACKGROUND: Among patients infected with human immunodeficiency virus type 1 (HIV-1), early and widespread use of prophylactic regimens against Pneumocystis carinii is changing the pattern of illnesses related to the acquired immunodeficiency syndrome (AIDS). METHODS: We conducted a subcohort analysis of 844 men with AIDS (87 percent of whom have since died) from a prospectively followed cohort of 2592 HIV-1-infected homosexual men. RESULTS: A total of 138 men received prophylaxis before the diagnosis of AIDS, but 39 (28 percent) nevertheless had P. carinii pneumonia at some time. Only four illnesses occurred more frequently in men who received P. carinii prophylaxis before the onset of AIDS: Mycobacterium avium complex disease, which developed in 33.4 percent, as compared with 17.3 percent of the 706 men who did not receive early prophylaxis; wasting syndrome (18.4 percent vs. 6.4 percent); cytomegalovirus disease (44.9 percent vs. 24.8 percent); and esophageal candidiasis (21.3 percent vs. 12.8 percent). Collectively, these four diseases accounted for the initial AIDS-related illness in 42.7 percent of those who received prophylaxis before the onset of AIDS, as compared with 10.7 percent of those who did not. During the three six-month periods before the diagnosis of AIDS (0 to 6, > 6 to 12, and > 12 to 18 months), the geometric mean CD4+ cell counts were 48, 87, and 147 per cubic millimeter, respectively, in men who received prophylaxis against P. carinii, as compared with 118, 211, and 279 per cubic millimeter in those who did not. CONCLUSIONS: M. avium complex disease, esophageal candidiasis, wasting syndrome, and cytomegalovirus disease are more common in HIV-infected patients who have received prophylaxis against P. carinii than in those who have not. Prophylaxis may delay the first AIDS illness for 6 to 12 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170402 · Cited by 1,199
KASLOW, R. A., OSTROW, D. G., DETELS, R., PHAIR, J. P., POLK, B. F., RINALDO, C. R., & STUDY, F. T. M. A. C. (1987) · American Journal of Epidemiology · doi:10.1093/aje/126.2.310 · Cited by 1,194
Self-citation(1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260401 · Cited by 487
Metabolic Disturbances and Wasting in the Acquired Immunodeficiency Syndrome
Flier, J. S., Underhill, L. H., Grunfeld, C., & Feingold, K. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270506 · Cited by 398
Crowe, S. M., Carlin, J. B., Stewart, K., et al. (1991) · PubMed · Cited by 330
Leoung, G. S., Feioal, D. W., Montgomery, A. B., Corkery, K., Wardlaw, L., Adams, M., Busch, D., Gordon, S., Jacobson, M. A., Volberding, P. A., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231201 · Cited by 299
Schneider, M. M. E., Hoepelman, A. I. M., Schattenkerk, J. K. M. E., Nielsen, T. L., van der Graaf, Y., Frissen, J. P. H. J., van der Ende, I. M. E., Kolsters, A. F. P., & Borleffs, J. C. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272603 · Cited by 282
Carr, A., Tindall, B., Brew, B. J., Marriott, D. J., Harkness, J. L., Penny, R., & Cooper, D. A. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-106 · Cited by 232
Girard, P.-M., Landman, R., Gaudebout, C., Olivares, R., Saimot, A. G., Jelazko, P., Gaudebout, C., Certain, A., Boue, F., Bouvet, E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305273282102 · Cited by 192
A Controlled Study of Inhaled Pentamidine for Primary Prevention of Pneumocystis carinii Pneumonia
Hirschel, B., Lazzarin, A., Chopard, P., Opravil, M., Furrer, H.-J., Rüttimann, S., Vernazza, P., Chave, J.-P., Ancarani, F., Gabriel, V., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241602 · Cited by 175
Cited by
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
Dunay, I. R., Gajurel, K., Dhakal, R., Liesenfeld, O., & Montoya, J. G. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-17 · Cited by 553
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
Lu, Y.-J., Gross, J., Bogaert, D., Finn, A., Bagrade, L., Zhang, Q., Kolls, J. K., Srivastava, A., Lundgren, A., Forte, S., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000159 · Cited by 493
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H., & Robinson, C. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904083401402 · Cited by 485
Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
Brodt, H. R., Kamps, B. S., Gute, P., Knupp, B., Staszewski, S., & Helm, E. B. (1997) · AIDS · doi:10.1097/00002030-199714000-00010 · Cited by 411
Martin, D. F. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090240037023 · Cited by 338
Metadata
- Authors
- Hoover, D. R., Saah, A. J., Bacellar, H., Phair, J., Detels, R., Anderson, R., & Kaslow, R. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1993-12-23
- Volume
- 329
- Issue
- 26
- Pages
- 1922-1926
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2325618846
- Cited by
- 406
- References
- 12
- FWCI
- 36.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Manifestations of AIDS in the Era of Pneumocystis Prophylaxis. https://app.cochat.ai/papers/10.1056/nejm199312233292604
- The paper
- Hoover, D. R., Saah, A. J., Bacellar, H., Phair, J., Detels, R., Anderson, R., & Kaslow, R. A. (1993). Clinical Manifestations of AIDS in the Era of Pneumocystis Prophylaxis. New England Journal of Medicine. https://doi.org/10.1056/nejm199312233292604
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.